1. Introduction {#s0010}
===============

The detection of lyssaviruses in bat species during the 20th century has highlighted the role this complex group of mammals plays as the principal reservoir for genetically diverse lyssaviruses. There are over 1,100 recognized species of bats classified within the order Chiroptera, although distinction between species is often technically challenging due to morphological similarities between different species. The determination of bat species has been aided by the development of genetic tools that enable differentiation between very closely related species alongside the more traditional morphological and ecological classification techniques. Such techniques serve to classify groups of mammals as accurately as possible. As a result, bat species continue to be reclassified.

Currently, the order Chiroptera is divided into 19 different families that are further classified into numerous subfamilies and genera ([Table 6.1](#t0010){ref-type="table"} ). Additional classification has subdivided this order into suborders Vespertilioniformes and Pteropodiformes. The Vespertilioniformes includes three superfamilies of bats: the Emballonuroidae (sheath-tailed bats of the Old and the New Worlds that are divided across two subfamilies); the Noctilionoidea (a large highly diverse subfamily with seven families---some of which include omnivorous bat species); and the Vespertilionidea (the largest superfamily of insectivorous bats that includes four distinct families). The Pteropodiformes includes the family Pterpodidae (the Old World fruit bats sometimes referred to as the 'megabats') and five Old World families of insectivorous or carnivorous bats that make up the superfamily Rhinolophoidea, namely: the Craseonycteridae, the Hipposideridae, the Megadermatidae, the Rhinolophidae and the Rhinopomatidae ([@bib111], [@bib232]). Across these suborders, bats can be described according to their feeding habits, and it is this feature of the bat life cycle that we will use to group lyssavirus infections of bats ([@bib5], [@bib94]) ([Table 6.1](#t0010){ref-type="table"}). Detection of viral pathogens within different bat species, often highlighted through epizootics that have affected both human and animal populations, have fuelled extensive research into bats as hosts of viral pathogens. More recently, the detection of coronaviruses ([@bib216]), filoviruses ([@bib235]) and henipaviruses ([@bib102]) have sparked further interest in bats as reservoirs of viral pathogens. However, it is the historical association of rabies virus and related lyssaviruses with bats that establishes this virus genus as the most notable zoonotic pathogen of bat origin.Table 6.1The Current Classification of Bat Species and Association with Lyssavirus InfectionSuborderSuperfamilyFamilyGenus Associated with Lyssavirus InfectionLyssavirus InvolvedRepresentative ReferencePteropodiformesPteropodidae (Old world fruit bats)Cynopterusunidentified[@bib223]EidolonLBV[@bib141]MOKV[@bib128]Eonycterisunidentified[@bib155]EpomophorusLBV[@bib42]; [@bib55]EpomopsLBV[@bib42]; Johnson et al., 2010MicropteropusLBV[@bib42]PteropusABLV[@bib257]; [@bib98]ARAV[@bib155]IRKV[@bib155]KHUV[@bib155]RousettusEBLV-1[@bib42]LBV[@bib159]ABLV[@bib15]RhinolophoideaHipposideridae (Old World leaf-nosed batsHipposiderosSHIBV[@bib145]Rhinolophidae (Horseshoe bats)RhinolophusEBLV-1[@bib42]; [@bib144]RABV[@bib120]VespertilioniformesEmballonuroidaeNycteridae (Slit-faced bats)NycterisLBV[@bib42]DUVV[@bib257]Emballonuridae (Sheath-tailed bats)SaccolaimusABLV[@bib42]; [@bib257]TaphozousABLV[@bib15]NoctilionoideaPhyllostomidae (Leaf-nosed bats)AnouraRABV[@bib225]ArtibeusRABV[@bib132]; [@bib198]CarolliaRABV[@bib225]ChrotopterusRABV[@bib225]DesmodusRABV[@bib75]; [@bib151]DiaemusRABV[@bib225]DiphyllaRABV[@bib45]GlossophagaRABV[@bib206]LeptonycterisRABV[@bib52]LonchorhinaRABV[@bib225]LophostomaRABV[@bib225]MacrotusRABV[@bib52]MicronycterisRABV[@bib206]Mormoopidae (Ghost-faced bats)MormoopsRABV[@bib52]PteronotusRABV[@bib206]Phyllostomidae (Leaf-nosed bats)PhyllostomusRABV[@bib225]PlatyrrhinusRABV[@bib225]SturniraRABV[@bib63]TrachopsRABV[@bib225]UrodermaRABV[@bib131]; [@bib189]VespertilionideaMolossidae (Free-tailed bats)CynomopsRABV[@bib225]EumopsRABV[@bib52]MolossopsRABV[@bib65]MolossusRABV[@bib210]NyctinomopsRABV[@bib52]TadaridaRABV[@bib52]TadaridaEBLV-1[@bib179]Miniopteridae (Bent-winged bats)MiniopterusABLV[@bib15]DUVV[@bib257]; [@bib159]EBLV-1[@bib42]; [@bib144]WCBV[@bib42]Vespertilionidae (Vesper bats)AntrozousRABV[@bib229]; [@bib41]BarbastellaEBLV-1[@bib179]CorynorhinusRABV[@bib229]; [@bib52]EptesicusRABV[@bib229]EBLV-1[@bib42]EudermaRABV[@bib52]HistiotusRABV[@bib243]LasionycterisRABV[@bib229]LasiurusRABV[@bib229]; [@bib52]MurinaIRKV[@bib42]MyotisARAV[@bib13]; [@bib96]RABV[@bib229]EBLV-2[@bib123]EBLV-1[@bib179]KHUV[@bib143]NyctalusEBLV-1[@bib179]RABV[@bib213]NycticeiusRABV[@bib52]PhiletorABLV[@bib15]PipistrellusRABV[@bib52]EBLV-1[@bib179]; [@bib135]RABV[@bib52]PlecotusEBLV-1[@bib178], [@bib36]ScotophilusABLV[@bib15]VespertilioEBLV-1[@bib137]; [@bib96]VespertilioRABV[@bib213]

Within bats, lyssaviruses have been characterized in only a small proportion of recognized species ([Table 6.1](#t0010){ref-type="table"}). However, since the first descriptions of rabies virus in bats ([@bib191]), other divergent lyssavirus species have been detected in a wide range of chiropteran hosts. There are currently 12 defined lyssavirus species and a further 2 recently described viruses that all appear to cause, where reported, rabies pathogenesis in humans and terrestrial carnivores ([Figure 6.1](#f0010){ref-type="fig"} ) ([@bib140]). Importantly, from the perspective of human vaccination, the different lyssavirus species have been divided into three phylogroups according to antigenic divergence and effectiveness of rabies vaccines. Phylogroup I viruses are all effectively neutralized by the current rabies vaccines, based on classical rabies virus strains while viruses categorized in phylogroups II and III are not neutralized by antibodies produced following standard rabies virus vaccination ([Figure 6.1](#f0010){ref-type="fig"}).Viruses include: *rabies virus* (RABV), which has been shown to infect a diverse range of species including bats in the New World and carnivores around the globe; *Lagos bat virus* (LBV), which has been detected in frugivorous bats, cats, and dogs but has not been associated with human infection ([@bib141], [@bib158]); *Mokola virus* (MOKV), which has caused natural infection of shrews, rats, cats, dogs, and two human cases ([@bib205]); *Duvenhage virus* (DUVV), which has been isolated from insectivorous bats and has caused human fatalities following exposure to bat bites ([@bib253]); *European bat lyssavirus*-1 (EBLV-1), which has been detected primarily in insectivorous bats but has also been associated with cross species transmission (CST) events into what are considered dead-end hosts, including sheep, a stone marten, cats, and humans ([@bib179]); *European bat lyssavirus*-2 (EBLV-2), which has been isolated from insectivorous bats alongside two documented human fatalities ([@bib81], [@bib83]); *Australian bat lyssavirus* (ABLV) is endemic in frugivorous and insectivorous bats across Australasia and has also 'spilled over' into human populations ([@bib175]); and *Irkut virus* (IRKV) that has caused human infection, *Aravan virus* (ARAV), *Khujand virus* (KHUV) and *West Caucasian bat virus* (WCBV) ([@bib13], [@bib143], [@bib139], [@bib142]) that are all associated with insectivorous bats, although only single isolates exist for each species ([@bib12]). Finally, in 2009, a virus isolated from a bat in Kenya and named *Shimoni bat lyssavirus* (SHIBV) ([@bib140], [@bib145]) was classified by the ICTV into the lyssavirus genus. Alongside these isolates, two currently unclassified lyssaviruses have also been identified that share high levels of genetic and morphological traits with the other lyssaviruses and are considered to be lyssaviruses. These have been reported in both volant and non-volant species and include the following. In 2010, a novel lyssavirus was detected in a Natterer's bat (*Myotis nattererii*) in Germany and was named *Bokeloh bat lyssavirus* (BBLV) ([@bib92]); and in 2011 a novel lyssavirus was detected in an African civet (*Civettictis civetta*) in Tanzania and was subsequently named *Ikoma Lyssavirus* (IKOV) from the location where the civet was captured ([@bib160]). Each of these isolates has yet to be classified within the lyssavirus genus but ultimately represents new lyssavirus species. Where novel lyssaviruses have been associated with bat infections, they are detailed further in sections that follow.Figure 6.1Phylogenetic distance between lyssavirus species based on substitutions per site.One hundred and ten lyssavirus nucleoprotein or full genomes sequences were analyzed in a Bayesian framework (BEAST v1.6.1). Posterior clade probabilities of all major nodes between lyssavirus species was \>0.99.

Along with the ecological evidence that Chiroptera are the original reservoirs of lyssaviruses, there is strong phylogenetic support for this with evidence of bat-derived viruses having evolved long before those RABV of terrestrial carnivore origin ([@bib18]). Despite this, there remain two distinct lyssaviruses that have not yet been detected in bat species: MOKV and IKOV. In the case of MOKV, the reservoir remains unclear. Numerous virus isolates have been reported from different species, including organ pools from shrews (*Crocidura* sp) in Nigeria (1968) ([@bib128], [@bib218]) and Cameroon (1974) ([@bib148]) ([@bib231]); domestic cats (*Felis catus*) in South Africa (1970, 1995--1998), Zimbabwe (1981--1982) ([@bib78]) and Ethiopia (1989--1990) ([@bib167]); and the rusty-bellied brush furred rat (*Lophuromys sikapusi*) in the Central African Republic (1983) ([@bib207]). Although human infection has been reported, a fatal ([@bib205]) outcome of infection was only recorded in one instance, and so the threat to the human population remains hard to determine ([@bib73], [@bib205]). Infections with MOKV are rare, with scant surveillance initiatives and limited diagnostic capacity, perhaps perpetuating our lack of knowledge of this lyssavirus ([@bib205]). Although MOKV antibodies have been detected in bat species, it is widely accepted that this is due to cross reactivity with antibodies against LBV, rather than evidence of MOKV circulation, although further sampling of different bat species may discover that MOKV also circulates in bats in the Old World ([@bib70], [@bib141]). The phylogenetic relationship and current thoughts regarding host susceptibility of MOKV have been reviewed by [@bib159].

In contrast to MOKV, where multiple isolates have been characterized and CST events have been identified, for IKOV, only a single isolate exists. The discovery of IKOV was the first detection of a non-rabies lyssavirus in African civets. Furthermore, the detection of this virus within the boundaries of the Serengeti National Park, Tanzania, during routine dog rabies surveillance activities highlights the importance of molecular characterization of virus isolates where surveillance initiatives are in place ([@bib160], [@bib167]). Analysis of sequence data generated from infected samples indicates that IKOV is the most divergent lyssavirus reported ([Figure 6.1](#f0010){ref-type="fig"}). The Serengeti National Park has been free of classical dog rabies for many years, with rabies cases clustering outside of the park in neighboring villages. Therefore, the isolated detection of this lyssavirus within the park from a terrestrial and largely solitary species strongly suggests that IKOV represents a CST event that could be of bat origin given the viruses close phylogenetic relationship with WCBV ([@bib160]).Without further isolates of this and more closely related lyssaviruses the reservoir for IKOV remains to be elucidated.

The evolutionary history of lyssaviruses within bats remains unresolved. Across the New World, only variants of classical RABV are associated with the infection of bat species, whereas other lyssaviruses remain completely absent across the New World in either volant or non-volant mammalian populations. Indeed, RABV has been detected in more than 50 species of insectivorous bat across the New World alone (see [Section 6.2](#s0015){ref-type="sec"}). In direct contrast, across the Old World there have been no detections of classical RABV strains in any bat species despite the presence of classical RABV in terrestrial species. Instead, 12 genetically divergent non-RABV lyssaviruses have been characterized from different bat species in the Old World. The reason for this situation remains unclear, however, tests for neutrality using various evolutionary algorithms on a panel of lyssavirus G protein sequences suggest neutral evolution occurs for lyssaviruses, and therefore niche-partitioning and radiation may explain this genetic pattern ([@bib18]). Interestingly, where different bat species have been associated with lyssavirus infection, there often appears to be, to some extent, a host restriction to infection with genetically distinct lyssaviruses. RABV itself may be exploiting relatively new niches in previously uninfected New World bats ([@bib229]). The focus of this chapter will be the association of different lyssavirus species with bats across the globe. Lyssavirus species will be described according to the bat species most frequently associated with infection and to avoid repetition, different species will be described according to their feeding patterns.

2. Lyssaviruses and Insectivorous Bats {#s0015}
======================================

In this section, we will discuss the association of classical RABV with numerous insectivorous bat species across the New World and comment on recent findings regarding the occurrence of CST events. We will then detail the occurrence of lyssaviruses in insectivorous bats in the Old World, concentrating on what appear to be principal reservoirs of each of the genetically distinct lyssaviruses.

2.1. Rabies Virus in Insectivorous Bats of the New World {#s0020}
--------------------------------------------------------

### 2.1.1. Historical perspectives {#s0025}

Prior to the 1950s, insectivorous bats were not considered a source of rabies in the New World. This changed in 1951 with the first documented case of human rabies resulting from a bat bite ([@bib72]). Human infection with insectivorous bat-derived RABV was again reported in the United States in 1954. In the summer of 1953, a seven-year-old boy was attacked and bitten by a rabid Florida yellow bat (*Lasiurus intermedius*) ([@bib244]). Subsequent surveillance for RABV in bats detected 40 cases between 1953 and 1958 ([@bib208]) and the direct transmission of RABV following the bite of a naturally infected insectivorous bat was shown experimentally through transmission to suckling mice ([@bib28]). This unequivocally highlighted the public health threat of rabid insectivorous bats and brought a new aspect of RABV epidemiology to the interest of the scientific community. Since these early reports of rabies in insectivorous bat populations, surveillance throughout the United States has detected rabies within indigenous insectivorous bat species from almost every state ([@bib174]). The first rabid bats in Canada were reported in 1957 ([@bib17]). Infected species included the big brown bat (*Eptesicus fuscus*), the little brown bat (*Myotis lucifugus*), and the silver-haired bat (*Lasionycteris noctivagans*), all reported from British Colombia. Detection of RABV infected insectivorous bats has been reported in Mexico since 1953 and South America since the 1960s ([@bib20]).

### 2.1.2. Natural and Experimental Infection of Insectivorous Bats {#s0030}

Insectivorous bats infected with RABV show a variety of disease signs that parallel infection in other mammals. A number of studies have described the susceptibility to infection and the clinical signs of disease in different insectivorous bat species. An early study by [@bib19] with the Mexican free-tailed bat (*Tadarida braziliensis*) confirmed the susceptibility to infection with a RABV isolated from the same species. Inoculation by the intracranial, intramuscular, and subcutaneous routes caused clinical disease in bats over a range of virus titers. Infected bats displayed signs of aggression, weakness, and anorexia with relatively short morbidity periods ranging from 4 to 20 days. Importantly, the intermittent excretion of virus in saliva was observed during this period, a feature of virus transmission that remains poorly understood. No evidence of virus excretion in the absence of disease development was observed. A recent infection study reported RABV infection of the big brown bat (*Eptesicus fuscus*), again using virus derived from the salivary glands of the same species ([@bib118]). In this study, bats infected intramuscularly exhibited weight loss, ataxia, and paresis. Transmission by bite is considered the most common method of RABV transmission in bats although there is evidence that aerosolized virus may cause infection in roosts where large numbers of bats congregate, such as the Mexican free-tailed bat ([@bib20]). Interestingly, experimental studies of North American RABV variants did not demonstrate evidence of disease in bats but showed seroconversion against RABV in response to exposure to aerosolized virus ([@bib61]). This may account for the levels of seropositivity observed in many bat populations around the world.

The striking feature of the ecology of lyssaviruses in the New World in comparison to that of the Old World is the diversity of bat species that appear to act as a virus reservoir. Prior to the introduction of molecular differentiation techniques it was impossible to differentiate between RABV isolates. The application of panels of monoclonal antibodies that targeted the virus nucleoprotein revealed antigenic differences between RABV and other members of the lyssavirus genus ([@bib255]). This approach demonstrated that RABV variants from North America could be differentiated and that different virus isolates were often associated with the reservoir host, including a range of non-flying species such as the red fox (*Vulpes vulpes*), racoons (*Procyon lotor*), and skunks (*Mephitis mephitis*) ([@bib221]). RABV from particular bat species also showed distinctive monoclonal antibody binding patterns. This was confirmed in both Canada ([@bib181]) and Mexico ([@bib242]). Importantly, it was also noted that the only lyssavirus species isolated in New World bats, and indeed all non-bat reservoirs, are variants of RABV, with no detection of non-RABV lyssaviruses being reported in the Americas. This has been confirmed by the application of phylogenetic techniques based on the RABV genome, which show that particular bat species are associated with specific RABV variants ([@bib109], [@bib229], [@bib243]). This is described further in later sections.

Numerous studies from individual states within the United States ([@bib40], [@bib46], [@bib53]) and Canada ([@bib181]) have reported multiple insectivorous bat species to be rabid, although it remains unclear what properties of bats make them a successful host for rabies virus. [Table 6.2](#t0015){ref-type="table"} compares the number of rabid bats reported in the United States between 1993 and 2000 ([@bib174]), with the numbers reported during 2010 ([@bib31]). A number of species are consistently reported with high levels of rabid submissions in both surveys, including the big brown bat (*Eptesicus fuscus*), the silver-haired bat (*Lasionycteris noctivagans*), the red bat (*Lasiurus borealis*), the hoary bat (*Lasiurus cinereus*), the little brown bat (*Myotis lucifugus*), and the Mexican free-tailed bat (*Tadarida braziliensis*). A comparison of four species of North American insectivorous bats that are most commonly reported as rabid ([Table 6.3](#t0020){ref-type="table"} ) indicates that traits such as colony size or geographical distribution do not support any particular hypothesis for their association with RABV. Indeed, it appears that the majority of North American bat species have been associated with RABV infection to varying extents. Recent phylogenetic analysis of RABV species isolated from North American bat species suggests that a model of CST followed by virus evolution within a particular host species fits the current diversity of the virus within insectivorous bats ([@bib229]). This implies that the majority of RABV transmissions within bats are intra-species events. It also suggests that the transmission of bat variants of RABV from a bat to other mammals, including humans, is a rare event. Experiments from the 1960s demonstrated that bat variants of RABV could infect a range of carnivores, although some species showed greater susceptibility than others ([@bib49], [@bib50]). In addition to inoculation by intramuscular injection, transmission to conspecifics was also demonstrated by repeated biting, in some cases over one hundred times, by an infected Mexican free-tailed bat ([@bib51]). Examples of bat variant infections in non-bat species have been reported, including from Canada where CST of a bat variant to a squirrel was reported ([@bib250]) as well as that of CST to two red foxes and a cow ([@bib251]). Such CST events are rare, and in the majority of cases there has been no evidence of onward transmission and maintenance of the infecting virus isolate within the new host species. However, two very rare events where CSTs have led to the maintenance of virus in the non-chiropteran host have been documented. One such event occurred on Prince Edward Island, Canada, where a cluster of rabies cases in red foxes (*V. vulpes*) was observed. Screening of the viruses isolated, with a panel of 15 monoclonal antibodies, suggested that they were of bat origin, possibly the little brown bat (*Myotis lucifugus*) ([@bib60]). A larger epizootic occurred following the emergence of rabies in the skunk (*M. mephitis*) population in the state of Arizona ([@bib150]). Sequence analysis of the RABV genome recovered from 19 skunks demonstrated that the source of the infection was likely to be from a RABV variant normally found in the big brown bat (*Eptesicus fuscus*). It is notable that CST events are more commonly reported with RABV than other lyssaviruses, possibly as RABV was more recently introduced into the New World bats. In contrast the bat-associated lyssaviruses in the Old World are considered to be evolutionarily older viruses (Tordo and Badrane, 2001; Noel Tordo, personal communication). These examples of sustained transmission among non-bat hosts are likely examples of how RABV emerged as a pathogen of carnivores, including domestic dogs.Table 6.2A Comparison of Bat Species Testing Positive for Rabies Virus from Two Reports from within the United States1993--2000[a](#tbl2fn1){ref-type="table-fn"}2010[b](#tbl2fn2){ref-type="table-fn"}SpeciesCommon NameNo. (% of species tested)*Antozous pallidus*Desert pallid bat21 (21.0)2 (6.9)*Eptesicus fuscus*Big brown bat1,216 (5.8)324 (3.8)*Euderma maculatum*Spotted bat1 (100)NR*Lasionycteris noctivagans*Silver-haired bat73 (12.9)14 (6.7)*Lasiurus borealis*Red bat47 (9.0)40 (23.5)*Lasiurus cinereus*Hoary bat97 (38.2)16 (33.3)*Lasiurus ega*Southern yellow bat7 (21.9)2 (33.3)*Lasiurus intermedius*Northern yellow bat3 (100)16 (18.8)*Lasiurus seminolus*Seminole bat0 (0.0)6 (30.0)*Lasiurus xanthinus*Western yellow batNR3 (100.0)*Myotis californicus*California myotis12 (3.6)0 (0.0)*Myotis evotis*Long-eared myotis19 (9.7)6 (14.6)*Myotis keenii*Keen's myotis11 (1.9)NR*Myotis lucifugus*Little brown bat96 (1.7)26 (2.9)*Myotis thysanodes*Fringed myotis0 (0.0)1 (50.0)*Myotis volans*Long-legged myotis3 (13.0)1 (16.7)*Myotis yumanensis*Yuma myotis4 (1.7)1 (5.9)*Myotis (unspeciated)*Unspeciated myotis41 (6.1)8 (8.4)*Nycticeius humeralis*Evening bat6 (9.7)5 (4.8)*Nyctinimops (Tadarida) femorosaccus*Pocketed free-tailed bat7 (13.2)NR*Tadarida macrotis*Big free-tailed bat3 (21.4)4 (57.1)*Parastrellus Hesperus*Canyon batNR14 (21.5)*Myotis austroriparius*Southeastern myotisNR1 (11.1)*Perimyotis subflavus*Tri-colored batNR5 (25.0)*Pipistrellus Hesperus*Western pipistrelle41 (21.2)NR*Pipistrellus subflavus*Eastern pipistrelle20 (17.1)NR*Plecotus townsendii*Townsend's big-eared bat3 (10.3)0 (0.0)*Tadarida brasiliensis*Brazilian/Mexican free-tailed bat214 (31.8)286 (65.4)*Tadarida unspeciated*Unspeciated free-tailed bats1 (33.3)NR*Unspeciated*Unspeciated batsNR648 (4.9)[^1][^2][^3]Table 6.3Comparison of Four Insectivorous Bat Species Associated with Transmission of Rabies to Humans in North AmericaCharacteristicTadarida BrasiliensisEptesicus FuscusLasionycteris NoctivagensPerimyotis Subflavus**Common name**Mexican/Brazilian free-tail batBig brown batSilver-haired batTri-colored bat**Distribution**Found throughout the Western hemisphere from northern United States to Eastern BrazilFound throughout southern Canada and United States to northern South AmericaFound throughout Canada, United States, and northern MexicoFound in the eastern regions of Canada and United States**Description**The species grows to about 9 cm in length and weighs around 12 gThe species grows to 12 cm in length and can weigh about 20 gThe species grows to about 10 cm in length, and adults can weigh between 8 and 12 gThe species grows to 9 cm in length, and adults weigh between 4 and 10 g**Colony size**Can reach up to 20 million in sizeMaternity colonies have been measured in the hundreds (300--600)Solitary species.Generally solitary, although females form small maternity colonies (\<20 individuals)**Roost in human structures**YesYesNoNo

### 2.1.3. Human Infection {#s0035}

Human infection with RABV of insectivorous bat origin is increasingly being recognized now that rabies has been eliminated from the domestic dog population in North America. At least 61 cases of human rabies between 1950 and 2007 were identified that could be attributed to transmission from bats ([@bib66], [@bib170]). In one extreme case, transplant material from a human case of rabies of bat origin was transferred to four recipients who then developed the disease ([@bib226]). [Table 6.4](#t0025){ref-type="table"} shows the number of human cases in the United States between 2002 and 2010. From these data, it is apparent that the transmission to humans, although rare, occurs from a small group of species. Investigation of one of these variants isolated from the eastern pipistrelle bat (*Pipistrellus subflavus*) suggested that this virus possessed certain virological characteristics, such as increased replication in epithelial cells and growth at lower temperatures, which may enhance the ability of the virus to be transmitted by a bite ([@bib260], [@bib177]). Interestingly, one rare survivor of RABV infection was believed to have been infected with a bat-variant of the virus ([@bib256]). Due to the recognition that rabies virus transmission from bats represents a high risk following contact, rabies post-exposure prophylaxis is recommended for any encounter with an insectivorous bat.Table 6.4Human Cases of Rabies in the United States of Bat OriginYearTotal Human Rabies CasesCases Due to Bat VariantsSuspected Bat Reservoir200233*Tadarida brasiliensisPerimyotis subflavusLasionycteris noctivagens/Perimyotis subflavus*200331*Lasionycteris noctivagens*200486*Tadarida brasiliensis* (×5)[a](#tbl4fn1){ref-type="table-fn"}Unknown bat200511Unknown bat200632*Tadarida brasiliensisLasionycteris noctivagens*200711Unknown bat200822*Tadarida brasiliensis* related*Lasionycteris noctivagens*200943Unknown bat*Perimyotis subflavusDesmodus rotundus*201022*Desmodus rotundusPerimyotis subflavus*[^4](Adapted from [@bib31].)

Until recently, the association of RABV with South American insectivorous bats has been neglected, mainly due to the burden of rabies cases associated with hematophagous species of bat. However, the report of a human rabies case transmitted from a Brazilian free-tailed bat (*Tadarida braziliensis*) ([@bib74]) highlighted the role that insectivorous bats play in the ecology of RABV and the risks to public health. An additional study updated the list of all bat species (insectivorous, frugivorous, and hematophagus) that have been shown to be positive for RABV in Brazil and included 41 species from the families *Molossidae, Phyllostomidae*, and *Vespertilionidae* ([@bib225]). The wealth of sequence data available for RABV isolates from New World bat species has led to detailed attempts to create genealogical trees that include all bat reservoir species ([@bib180]). This approach confirmed earlier findings on the association between particular virus lineages and bat species separating RABV variants into at least 14 groups. A general observation was the influence of geographical separation of certain species that are located in both North and South America. For example, the RABV variants associated with *Tadarida braziliensis* formed two clusters dependent on the geographical origin of the bat. This was consistently shown for both *Myotis* and *Eptesicus* species. The surprising exceptions to this were those RABV viruses associated with *Lasiurus* species (*L. cinereus*, *L. borelialis* and *L. ega*), which formed a single group ([@bib180]). The reasons for this close association between North and South American RABVs are uncertain. However, the hoary bat (*L. cinereus*) is known to make large distance migrations although this is limited to migration from the interior of the United States to over-wintering sites on the coastline and possibly central Mexico ([@bib56]). It is possible that there is sufficient overlap of migrating hoary bat populations between Canada and Brazil to have enabled the observed passage of RABV between both continents.

2.2. Rabies in Insectivorous Bats of the Old World {#s0040}
--------------------------------------------------

In direct contrast to the situation seen in the New World, where closely related RABV isolates are associated with numerous different insectivorous bat species, in the Old World highly divergent non-RABV isolates have been reported from very few bat species. Due to the paucity of knowledge about other lyssaviruses of the Old World associated with the infection of insectivorous bats, we concentrate on what is known about infection with the EBLVs.

### 2.2.1. Lyssavirus Infection of Serotine Bats {#s0045}

Serotine bats are considered to play a key role in the epidemiology of bat rabies in Europe. Indeed, the first link to a rabies-like infection was established in 1954 when the first report of a rabid bat in Europe was made in Germany ([@bib173]). The species of bat involved in this incident was not reported, although subsequent detections of lyssaviruses in serotine bats may suggest that early bat rabies cases in Europe involved this species. Only with the advent of antigenic typing and molecular tools could the virus isolated in European bats be distinguished from classical RABV and other lyssavirus species ([@bib36], [@bib211]). Serotine bats belong to the genus *Eptesicus* of the subfamily Vespertilioninae, chiropteran family Vespertilionidae of the suborder Vespertilioniformes. Up to 39 insectivorous species of *Eptesicus* are known to exist ([@bib112], [@bib186]). Of the 39 species of *Eptesicus*, *E. serotinus isabellinus* and *E. serotinus* deserve special attention, as they are primarily associated with transmission of EBLV-1. *E. serotinus* is the most widespread and abundant Palaearctic species of *Eptesicus* in Europe. Its present range extends from the Atlantic Ocean and the Mediterranean basin to Northern Denmark and the Eastern parts of the Eurasian continent as far as the Pacific seaboards, with evidence for an expansion into Scandinavia ([Figure 6.2A](#f0015){ref-type="fig"} ) ([@bib113]). *E. s. isabellinus* has been reported in North Africa and Southern Iberia and is considered to be genetically divergent from *E. serotinus* ([@bib115]).Figure 6.2Distribution of the insectivorous bat species found to be infected with, and reported cases of, EBLV-1 and EBLV-2. A) Range of *E. serotinus* (Red) and *E. isabellinus* (Blue) and reported EBLV-1 cases (dots); B) Range of *M. daubentonii* (Red) and EBLV-2 (dots) cases in Europe 1977--2010. Distribution of bats according to IUCN and Vazquez- Moron, 2011.

#### 2.2.1.1. Epidemiology of Lyssavirus Infection of Serotine Bats {#s0050}

Serotine bats are one of the most studied lyssavirus reservoir species, revealing some fundamental insights into virus--host interactions and, hence, possibly the epidemiology of bat lyssavirus infections in insectivorous bat species in the Old World. *E. serotinus* and *E. s. isabellinus* are known to be associated with EBLV-1 and thus, are considered the primary reservoir hosts for this particular bat-associated lyssavirus. Interestingly, of the 959 cases of bat rabies officially reported between 1977 and 2010 to the database of the Rabies Bulletin Europe (RBE) about 95% have been observed in *E. serotinus* ([@bib209]). The involvement of *E. s. isabellinus* in the epidemiology of EBLV-1 was demonstrated in southern Spain when rabid serotine bats were later genetically identified as Isabelline serotine bats ([@bib194], [@bib239]; Vazguez-Moron et al., 2008b). During the past 50 years, the vast majority of rabid serotine bats in Europe have been diagnosed in densely populated countries of The North European Plain that covers large areas of Denmark, The Netherlands, and Germany. However, this clustering of reported bat rabies cases suggests a bias in surveillance activities that reflects the location of established networks of bat handlers and their activities ([Figure 6.2A](#f0015){ref-type="fig"}). Regardless of this potential bias in sampling, it seems clear that the serotine bat has particular host species-specific ecological traits that may promote the maintenance and transmission of EBLV-1. Indeed *E. serotinus* is a very adaptable species with habitats including semi-desert, temperate, and subtropical dry forest, Mediterranean-type scrubland, farmland, and suburban areas. Furthermore, in contrast to other bat species, it is not experiencing a decline in population size. Hence, a greater abundance of *E. serotinus* might favor virus amplification and may explain the clusters of bat rabies cases detected in densely populated areas. The northern distribution range of serotine bats seems to be limited by a threshold level of mean summer temperatures ([@bib103]). Interestingly, the great majority of EBLV-1--infected *E. serotinus* have been reported from this northern range. This is supported by surveillance for EBLV-1 in Germany, a country with a north-south gradient in elevation where over several decades notably higher numbers of cases have been reported from the northern regions of the country, where the highest density of *E. serotinus* is found ([@bib179]). Taking this into account might explain why in some European countries with existing *E. serotinus* populations, no or only sporadic cases of EBLV-1 infections are observed ([@bib258], [@bib237]). Despite the limitations of surveillance, based on the current knowledge of EBLV-infections it is likely that serotine bats may be infected with EBLV-1 throughout Eurasia ([@bib209]). For reasons unknown, however, long-term active and passive surveillance for lyssaviruses has provided no evidence for EBLV-1 circulation in serotine bat populations in southern England, although specific antibodies have been detected in a single serotine bat ([@bib104]). This disparity between mainland Europe and the UK may be due to the limited geographical distribution and population size of *E. serotinus* within the UK preventing EBLV-1 persistence.

The molecular characterization of EBLV-1 isolates from serotine bats has revealed valuable clues to virus--host interactions and help resolve questions surrounding the epidemiological puzzle of this virus--host relationship. With approximately 5 × 10^5^ substitutions per site per year the evolutionary rate of nucleotide substitution of EBLV-1 is one of the lowest recorded for RNA viruses, suggesting that the current genetic diversity of the virus in serotine bats arose between 500 and 750 years ago ([@bib62]) although other estimates predict a more recent evolution ([@bib259]). Either way, this is believed to reflect an evolutionary stability between EBLV-1 and its two host species ([@bib62]). Based on unique molecular traits, however, there is evidence that the phylogeny of this virus is more complex than previously thought and clearly associated with geographically different host evolutionary history ([@bib240]). Early genomic sequencing indicated that in European populations of serotine bats two distinct genetic lineages of EBLV-1 evolved, which seemed to geographically cluster ([@bib7]). Serotine bats throughout the North and East European Plains, for example, located between the North Sea and the Baltic Sea to the north, and the Central European Highlands to the south, are infected by EBLV-1 lineage "a." These isolates have been reported to exhibit an extremely high sequence identity, as confirmed by phylogenetic analysis of the N-gene ([@bib7], [@bib62]; Freuling et al., 2008; [@bib237]). Despite its extensive West-East geographic range, the low genetic diversity in connection with a consistent star-like structure of the phylogenetic network suggests a relatively recent introduction, evolution, and rapid expansion of EBLV-1a variants in populations of serotine bats in these parts of Europe ([@bib240]). Although in early studies no, or only a less pronounced, correlation between geographic and genetic distances was observed with lineage 1a using both a hypothetical introduction point or a model based origin of a putative common ancestor ([@bib7], [@bib62]), cluster analysis showed a significant positive correlation between genetic and temporal and spatial distance based on N-gene sequence and provided evidence for a geographical segregation ([@bib88], [@bib93]). EBLV-1a isolates from serotine bats within certain geographical regions of The Netherlands and Germany have almost identical nucleotide sequences. This indicates genomic stability during the transmission cycle of these virus variants, with little geographic spread or intermixing ([@bib88], [@bib237]). Serotine bat colonies usually number 10 to 50, although occasionally up to 300 individuals have been recorded ([@bib113], [@bib186]). Considering the sedentary nature of the serotine bat ([@bib113]) transmission of EBLV-1a over long distances may not play a major role in EBLV-1 epidemiology ([@bib88], [@bib237]) and therefore somewhat contradicts a rapid expansion hypothesis of EBLV-1a variants in populations of serotine bats.

In contrast to EBLV-1a, EBLV-1 lineage 'b' appears to follow a more North-South distribution ([Figure 6.2A](#f0015){ref-type="fig"}) and is genetically more heterogeneous ([@bib7]). This heterogeneity is reflected by the presence of diverse sublineages that are predominantly associated with populations of serotine bats on the Iberian Peninsula, in The Netherlands, France, and southwestern Germany ([@bib62], [@bib179]). A recent phylogenetic analysis segregated *E. s. isabellinus* sequences from the *E. serotinus* sequences and hypothesized that the *E. s. isabellinus* isolates form a further independent lineage, EBLV-1 lineage 'c' ([@bib240]). Considering that serotine bats do not normally migrate over large distances, recent single discoveries of EBLV-1b in Central Poland and Eastern Germany (Müller et al., unpublished data; [@bib224]) may suggest that the distribution of this lineage is more widespread in Europe than previously considered. As there is evidence of genetic flow between *E. s. isabellinus* populations on both sides of the Strait of Gibraltar, there is reason to believe that North African con-specifics may also be infected with this lineage ([@bib126]).

It remains unclear, however, exactly how populations of serotine bats in different parts of Europe favor the current geographic distribution and clustering of the two or three different EBLV-1 lineages. Additional genetic data from both the host species and virus isolates are required to fully understand the evolutionary EBLV-1-serotine bat interaction. In any case, serotine bats in the westernmost parts of the North European Plains represent the only geographical location where both EBLV-1a and EBLV-1b are detected ([@bib237], [@bib195]). However, as co-infection of serotine colonies or infection of individuals with both lineages has not been reported, this may suggest independent infectious cycles among *E. serotinus*. Interestingly, results of recapture data and long-term active rabies surveillance in maternity colonies of *E. s. isabellinus* strongly suggest close communities in which variants of EBLV-1 independently circulate ([@bib241]). Also, provided the hypothesis of an inverse correlation between CST of lyssaviruses and phylogenetic distance between bat species as recently demonstrated for North American bat RABV also applies to European bats ([@bib229]), then future targeted surveillance should discover the existence of known or new EBLV-1 lineages.

#### 2.2.1.2. Clinical Infection and Disease Patterns {#s0055}

Based on the limited observational studies and experimental data of infection in serotine bats, our understanding of the transmission and pathogenesis of EBLV-1 under natural conditions is incomplete. Hence, clinical implications of EBLV-1 infections in serotine bats are discussed. It is clear that *E. serotinus* is known to succumb to clinical infections and therefore is likely to be submitted for rabies diagnosis ([@bib90] ). However, reports on EBLV-1 related clinical signs in serotine bats are rare and stem either from animals kept in captivity in bat sanctuaries or experimental studies. Although no information exists concerning the incubation period in naturally infected *E. serotinus* bats, the incubation periods in experimentally infected bats varies depending on the route of inoculation, with the intracerebral route leading to the shortest incubation period (7--13 days), followed by subcutaneous (17--18 days) and intramuscular (26 days) routes ([@bib91]). Because intranasal inoculation was ineffective in experimentally inducing clinical rabies, transmission of EBLV-1 among serotine bats via non-bite exposures in nature seems highly unlikely ([@bib122]). The subcutaneous route of inoculation was relatively efficient in inducing mortality and concomitant shedding of virus in saliva immediately before the development of disease, while intramuscular inoculation was less efficient. Interestingly, experimental intramuscular infection of RABV in Mexican free-tailed bats (*Tadarida braziliensis*) caused fewer virus-positive salivary glands compared with that resulting from subcutaneous infection ([@bib19]). From these experimental studies it has been postulated that this may indicate a host-specific adaptation of EBLV-1 and that the subcutaneous route of infection is highly likely to mimic natural transmission among natural hosts via multiple dose infection ([@bib91]). In contrast, inoculation of the North American sibling species *E. fuscus* with EBLV-1 by the intramuscular route led to the development of disease in 50% of challenged animals ([@bib85]). Of note, the detection of EBLV-1 infection in infected *E. serotinus* taste buds was observed, mimicking studies with human rabies ([@bib117]). The significance of this observation, however, remains unclear with respect to potential excretion of virus ([@bib90]).

Only a few detailed descriptions are available of naturally EBLV-infected serotine bats and most of these have involved human contacts ([@bib245]). Where clinical disease in naturally infected serotine bats has been observed, animals demonstrated to a lesser or greater degree the following signs: inability to fly, loss of weight, weakness, hypersensitivity for high frequency sounds, prolonged vocalization and uncontrolled wing beats after high frequency sounds, and a strong tendency to bite and react aggressively to stimuli ([@bib9], [@bib10], [@bib39]). Experimentally, EBLV-1 causes disease in serotine bats indistinguishable from that observed with RABV infection of North American bats with clinical signs being consistent with those described above ([@bib91]). Whether the different EBLV-1 lineages exhibit differences in pathogenicity and result in different disease patterns in serotine bats is currently unknown. The same applies to the recently discovered mutated forms of lineages 1a and 1b possessing either single or hexameric nucleotide insertions within the 3' untranslated region (UTR) of the nucleoprotein or 35 nucleotide deletions within the UTR between the glycoprotein (G) and polymerase (L) gene ([@bib93], [@bib121]). The effects of these changes on viral replication remains elusive, as such mutations had not been previously described for lyssaviruses ([@bib104]).

It appears that *E. serotinus* and *E. s. isabellinus* can survive infection with EBLV-1, as evidenced by the repeated captures of individual seropositive bats over a number of years during serological surveillance initiatives ([@bib104]) and experimental infection ([@bib91]). In the latter case, serotine bats surviving in this instance should be considered to have had an aborted infection ([@bib24]). Although no seroconversion was detected in serotine bats from the Balearic Islands (Spain) and Switzerland ([@bib168], [@bib215]), measurable virus neutralizing antibody (VNA) titers have been detected in free-living con-specifics from several countries with reported prevalences for seroconversion in single colonies in the UK (0.3%) (Brookes et al., 2005; [@bib104]), Germany (5.1%) (Müller et al., unpublished data), in different studies across Spain (4.8%, 7.7%, 19%, and 74%) ([@bib194]), and in France (25%) ([@bib197]). Similar observations were made in Spanish colonies of *E. s. isabellinus*, where the overall seroprevalence was estimated to be 9% ([@bib71], [@bib241]). However, in an experimental study, none of the *E. serotinus* infected with EBLV-1 developed VNAs ([@bib91]), while in the North American sibling species *E. fuscus* VNAs were detected in survivors and deceased animals ([@bib85]). Although these serological observations in free-living *Eptesicus spp*. have to be interpreted with caution (see the following), this has led some to hypothesize that endemic EBLV-1 is associated with subclinical or mild disease ([@bib241]). The only experimental study with EBLV-1 in its host reservoir did not provide any evidence for a subclinical carrier state in serotine bats ([@bib91]) as repeatedly suggested ([@bib71], [@bib215]), and hence the existence of such a state remains to be conclusively demonstrated. The assumption that the clinical expression of EBLV-1 in bats is a non-fatal, extra-neurological infection without important consequences for the health of the *E. serotinus* populations ([@bib71], [@bib240]) is disproved by experimental data and routine rabies diagnostics. Further studies, however, are needed to investigate the circumstances under which neurological manifestations develop in these bats ([@bib239]).

#### 2.2.1.3. Serotine Bats as Vectors for EBLV-1 {#s0060}

Limited experimental data has shown that other insectivorous bat species, for example, Daubenton's bats (*Myotis daubentonii*), Brandt's bats (*Myotis brandtii*), common pipistrelle bats (*Pipistrellus pipistrellus*), Egyptian flying foxes (*Rousettus aegyptiacus*), and big brown bats (*E. fuscus*), are susceptible to infection with EBLV-1 ([@bib32], [@bib85], [@bib137], [@bib135], [@bib236]). Because European *Eptesicus* bats are known to cohabit in both mating and wintering roosts with other insectivorous bat species it is not surprising that other bat species have been infected with EBLV-1. Reports of sporadic detection of EBLV-1 in the noctule Bat (*Nyctalus noctula*), the Nathusius' pipistrelle bat (*Pipistrellus nathusii*), the common pipistrelle bat (*Pipistrellus pipistrellus*), the greater horseshoe bat (*Rhinolophus ferrumequinum*), and the parti- colored bat (*Verspertilio murinus*) ([@bib130], [@bib179], [@bib213]) have been made. Further to this, EBLV-1 RNA has been detected in the Schreiber's bent-winged bat (*Miniopterus schreibersii*); the Natterer's bat (*Myotis nattereri*); the greater horseshoe bat (*R. ferrumequinum*) and the greater mouse-eared bat (*Myotis myotis*) from Spain ([@bib215]), indicating that EBLV-1 may circulate in the absence of clinical disease in a range of other bat species under natural conditions. However, whether high EBLV-1 specific seropositivity in free-living bat species such as *M. nattereri*, *R. ferrumequinum*, *M. schreibersii*, and *M. myotis*, and even antigen detection in blood clots in *M. myotis* ([@bib6], [@bib215]) suggest CST, or evidence of independent reservoirs for these viruses remains questionable.

EBLV-1 is rarely transmitted to terrestrial mammals and humans. Incidents of CST infections of EBLV-1 in sheep, a stone marten (*Martes foina*), and domestic cats have been reported ([@bib59], [@bib178], [@bib202]). Furthermore, in contrast to infection with RABV of terrestrial wildlife in Europe, peripheral inoculation of serotine-associated EBLV-1 in terrestrial mammals, including foxes, ferrets, cats, dogs, and sheep demonstrated limited susceptibility of those species ([@bib196], [@bib246]). The virulence of EBLV-1 is considered to be low with sheep and foxes surviving intramuscular inoculation with a high dose of virus ([@bib22], [@bib38], [@bib48], [@bib76], [@bib247]).

Although numerous human contacts with serotine bats, primarily from handling sick or injured animals, have been reported ([@bib37]), only two EBLV-1 induced human casualties have been conclusively demonstrated: in Ukraine in Voroshilovgrad (1977) and in Belgorod, Russia (1985) ([@bib80]). Although both cases are known to have involved transmission from a bat to human, the species of bat was not defined for either case. Furthermore, the Russian case was genetically typed as being EBLV-1 while the Ukraine case is only assumed to be EBLV-1 from antigenic profiling ([@bib34], [@bib214]). Two further reports of human deaths have been reported following encounters with bats in continental Europe, although neither has been confirmed as EBLV-1 nor has an involvement of *E. serotinus* been confirmed ([@bib24]). In conclusion, the probability of serotine bats transmitting EBLV-1 to other species including humans is minimal and there is no evidence that serotine bats will cause EBLV-1 associated epizootics among terrestrial animals or significant human fatalities ([@bib37]).

#### 2.2.1.4. Control of Serotine Bat-mediated Rabies {#s0065}

In contrast to North Africa and South Asia, where no specific conservation actions are known, across Europe there are internationally recognized legal frameworks in place for the protection of European bats through the Bonn Convention (Eurobats), the Bern Convention, and Annex IV of the EU Habitats and Species Directive. Hence, all bat species are protected by national legislation in member states ([@bib113]). Therefore, any specific population control measures aimed at reducing disease prevalence in serotine bats is prohibited and from a scientific point of view also unwarranted ([@bib37]). Rather, in keeping with ongoing conservation measures, the main focus of activities should be on (i) the establishment of adequate surveillance, (ii) objectively increasing public awareness about bat rabies and (iii) targeted pre- and post-exposure prophylaxis (PEP). Although guidelines on passive and active bat lyssavirus surveillance were established and adopted by the United Nations ([@bib11]) and on request from the European Food Safety Authority ([@bib47]), it is not clear what affect these guidelines will have on European bat rabies surveillance ([@bib209]). Vaccination of serotine bats using modified live RABV vaccines as discussed for vampire bats ([@bib2]) is largely unfeasible. Instead, consistent preventive vaccination of all persons working with bats and PEP of all persons with bat exposures should be given as priority as the available human inactivated rabies vaccines stimulate cross neutralizing antibodies and therefore are considered to confer cross protection with EBLV-1, -2 and BBLV ([@bib76], [@bib147], [@bib156]; Freuling et al., unpublished data). Any media panic and fearmongering that may have a negative impact on serotine bat populations should be avoided.

### 2.2.2. Lyssavirus Infection of Myotis Bats {#s0070}

As observed with *E. serotinus* and EBLV-1, there appears to be a strong association of EBLV-2 with *Myotis* species. The *Myotis* genus comprises more than 100 species in three main phylo-geographic clades, that is, North America, South America, and the Old World ([@bib146]). In the latter, rabies in Daubenton's bats (*Myotis daubentonii*) and pond bats (*Myotis dasycneme*) has been genetically characterized as EBLV-2. While the pond bat is confined to Central and Eastern continental Europe, the Daubenton's bat is widely distributed throughout Eurasia ([@bib227]) ([Figure 6.2B](#f0015){ref-type="fig"}).

In fact, only after the tragic death of a Swiss biologist in Finland in 1985 and subsequent characterization of the causative agent did it become evident that bat rabies in Europe at that time was caused by two different lyssavirus species, EBLV-1 and 2 ([@bib36], [@bib154]). The first isolation of EBLV-2 from a bat was made in The Netherlands from a Pond bat ([@bib188], [@bib187]). From 1987 to 1993, five Pond bats tested rabies positive, of which the majority were characterized as EBLV-2 ([@bib62], [@bib187]). Despite intensive surveillance efforts, no further cases of rabies in the Pond bat were detected in The Netherlands ([@bib237]). All of the Dutch EBLV-2 isolates form a separate cluster, away from the other EBLV-2 sequences ([@bib62]), possibly reflecting geographical or host species relationships. However, since no other *M. dascyneme* associated isolates have been characterized elsewhere and given the distant relationship between these two bat species ([@bib203]), it is also likely that cases in *M. dascyneme* resemble CST events from Daubenton's bats. In fact, rabies was also reported from Pond bats in Denmark and Germany ([@bib127]), and Daubenton's bats in Russia. However, the isolates from Denmark and Germany were not characterized, and, surprisingly, isolates from Russia appeared to be RABV, suggesting possible contamination in the diagnostic laboratory (Kuzmin and Rupprecht, 2007).

Elsewhere in Europe, EBLV-2 has been isolated sporadically from the Daubenton's bat in Switzerland ([@bib168]), the United Kingdom ([@bib25], [@bib254]), Germany ([@bib89]) and Finland ([@bib119]). A Daubenton's bat captured during net trapping in Finland showed abnormal behavior, died, and subsequently tested EBLV-2 positive. Molecular characterization then indicated that the first human victim in 1985 had contracted the infection in Finland ([@bib119]). Besides this Finnish case, a second human rabies case occurred after EBLV-2 infection of a bat biologist in the UK (*Supplementary Case history box 6.1*) ([@bib83]; [@bib183]). No further EBLV-2 CST events have been reported.

#### 2.2.2.1. Natural and Experimental Infection of Myotis Species {#s0075}

As with disease progression seen in natural infection of bats with EBLV-1, the infection of *Myotis* species with EBLV-2 have involved vocalization, agitation, and aggressiveness. Both naturally and experimentally infected bats exhibited a reduced food and water intake a few days before they died ([@bib87], [@bib89], [@bib125]). Occasionally, infection of bats has been observed during the rehabilitation of grounded bats in specialist wildlife centers. In such cases, the apparent 'activation' of virus can come following considerable incubation periods ranging from seven weeks ([@bib123]) to as long as nine months ([@bib190]). In comparison, a captive Daubenton's bat infected by experimental subdermal inoculation with a standard dose developed disease after 32 days ([@bib124]) although numerous alternative routes of infection failed to cause clinical disease.

Following both experimental infection ([@bib124]) and natural exposure, EBLV-2 RNA was detected in the brain and to a lesser extent in other organs, including the tongue and salivary glands ([@bib25], [@bib87], [@bib89], [@bib123]). The heterogeneous pattern in different non-neuronal organs may be linked to the relative time point of death and the degree of centrifugal viral dissemination rather than a specific effect of EBLV-2 ([@bib125]).

How EBLV-2 persists in its natural host is still poorly understood. In the UK, where a passive bat rabies surveillance initiative has been established (Brookes et al., 2005; [@bib104]), EBLV-2 specific antibodies are often detected at low levels within bat populations, suggesting that the virus is endemic within the Daubenton's bat population ([@bib23]). Serosurveillance studies have also indicated a low level seroprevalence in the bat population in the UK ([@bib104]), although the mechanisms of persistence at the population level remain unclear. Virus neutralizing antibodies have also been detected in Daubenton's bats in Switzerland and Sweden ([@bib168], [@bib184]). It is postulated that transmission of EBLV-2 is through biting or scratching, as virus was detected in oral swabs of a subdermally infected bat in an experimental setting. Furthermore, oral swabs from individual Daubenton's bats from Scotland (2008) and Switzerland (2009) yielded EBLV-2 specific RNA, but not viable virus ([@bib209]). The perpetuation of EBLV-2 infection in Daubenton's bat populations is driven by virological and ecological parameters ([@bib245]), and rates may confer a virus--host co-evolutionary process. Models indicate that the behavior of the Daubenton's bats result in high gene flow, which may allow EBLV-2 to become established and rapidly spread throughout the population ([@bib220]).

As well as the infection of Myotis bats with EBLV-2, several other lyssaviruses have been isolated from Myotis species. In 1991, an apparently healthy lesser mouse-eared bat (*Myotis blythi*) captured in the Aravan district, Kyrgyzstan, tested positive for rabies by the mouse inoculation test ([@bib136]). In 2001, near the town of Khujand, Tajikistan, a whiskered bat (*Myotis mystacinus*) that was grounded and collected by hand also tested positive ([@bib33]). Subsequent characterization of the isolated viruses revealed they represent new lyssavirus species Aravan virus (ARAV) and (KHUV) Khujand virus. Little is known about the epidemiology of these lyssaviruses in bats, as only single isolations have been made. Also, as the taxonomy of whiskered bats was modified, it is likely that the bat species from which KHUV was isolated was actually the steppe whiskered bat, *Myotis aurascens* ([@bib30]).

In 2009, a virus isolated from a Natterer's bat (*Myotis nattereri*) from Germany was shown to be antigenically and genetically distant to all previously known lyssaviruses (Supplementary Case history box 6.2), and the virus detected, named Bokeloh bat lyssavirus (BBLV), ([@bib92]). Natterer's bats are among the species routinely submitted under passive surveillance schemes in Europe, albeit in low numbers ([@bib209]). It is thus enigmatic why this virus was only discovered recently. Surprisingly, viral RNA (EBLV-1) was previously detected in the brain of a Natterer's bat in Spain, although both fluorescent antibody testing and virus isolation was unsuccessful ([@bib215]). Likewise, high levels of VNAs in the greater mouse-eared bat from Spain ([@bib6]) is only corroborated by viral RNA (EBLV-1) detected in the brain of a few individuals ([@bib215]). Elsewhere in Europe, only two cases of bat rabies were confirmed in greater mouse-eared bats, one in Germany and one in Poland ([@bib209]). Unfortunately, in both instances the viruses involved were not fully characterized. The isolation of closely related lyssavirus species, that is, EBLV-2, ARAV, KHUV, and BBLV from *Myotis* species suggests that this bat genus may play a key role in the transmission and maintenance of this clade of phylogroup I lyssaviruses.

### 2.2.3. Lyssavirus Infection of Other Insectivorous Bat Species {#s0080}

Alongside the infection of serotine and myotis species there have been a number of individual isolations of lyssaviruses from other bat species. Of these, bats within the *Miniopteridae*, commonly referred to as the bent-winged bats and found across much of Africa, Asia, Australia and southern Europe, have been associated with several highly divergent lyssavirus species. The first lyssavirus to be associated with *Miniopterus spp*. was first isolated in 1970 following the death of a human that had been bitten in South Africa, by an insectivorous bat, while sleeping. The virus was named Duvenhage virus (DUVV) after the individual bitten, and it is thought from the description given that it was most likely a bent-winged bat ([@bib169]). During the 1980s there were two further reports of DUVV from insectivorous bats. In 1981, the virus was isolated from what was believed to have been a bent-winged bat caught by a domestic cat in Makhado town, Limpopo Province, South Africa ([@bib129]), although again the species of the infected bat was never confirmed, and in 1986 an Egyptian slit-faced bat (*Nycteris thebaica*) that was trapped during a survey in Zimbabwe also tested positive for DUVV ([@bib79]). Another lyssavirus predominantly isolated from African bats, LBV has also been isolated from the insectivorous Gambian slit-faced bat (*Nycteris gambiensis*) ([@bib158]), although LBV is predominantly associated with the infection of frugivorous bats (see [Section 6.4](#s0110){ref-type="sec"}).

Two further human cases involving DUVV have also been reported. The first occurred in 2006 when a 77-year-old man was scratched on the face by an insectivorous bat in North West Province, South Africa. The individual was unknowingly infected and died 14 days following the onset of clinical disease ([@bib193]). The second case involved the infection of a 34-year-old woman who died 28 days after the onset of clinical disease ([@bib238]). The lack of adequate rabies surveillance and characterization of isolates prevents the development of a detailed understanding between lyssaviruses and bats in Africa. Moreover, the number of bat-associated human cases of rabies in Africa remains unknown.

The common bent-wing bat (*M. schreibersii*) became the subject of further interest among rabies scientists when a bat of this species was net-trapped in Russia near the Georgian border and subsequently tested rabies positive for lyssavirus infection ([@bib33]). The virus was only detected conclusively as being a member of the lyssavirus genus following fluorescent antibody testing (FAT) on brain material from mice inoculated with suspect material via the intracranial route that subsequently developed neurological disease. The virus, named West Caucasian bat virus (WCBV), was a genetically divergent bat-derived member of the lyssavirus genus with no serological cross-reactivity to other lyssaviruses ([@bib139], [@bib85], [@bib142]; Horton et al., 2010). Given this observation, neutralizing antibodies against WCBV in *Miniopterus* bats collected in Kenya ([@bib142]) indicate that WCBV or some other antigenically similar virus also circulates in Africa and in the rest of the Old World where *Miniopterus* bats are abundant ([@bib138]). The recent discovery of IKOV makes these data even more intriguing, although the serological response to IKOV has not yet been defined with respect to the cross- neutralization of other lyssaviruses.

It is unknown whether the common bent-wing bat is also affected by European lyssavirus species, although EBLV-1 RNA was detected in one *Miniopterus* specimen in Spain ([@bib215]). Virus neutralizing antibodies that did not cross-react with WCBV were also found in *M. schreibersii* from France and Spain ([@bib215]). A serological survey of bats in the Philippines showed that virus neutralizing antibodies to Australian bat lyssavirus were most prevalent in *M. schreibersii* (4/11, 36%) ([@bib15]). However, in none of the 422 bats of this species tested was evidence for an ABLV infection detected ([@bib77]). In any case, the association of *M. schreibersii* with numerous lyssaviruses has led to the suggestion that this species may facilitate cross-continental transmission of different lyssavirus species. This is supported by the global distribution of *M. schreibersii* from southern Europe and Africa and across the Middle East and Caucasus mountains.

Another insectivorous species associated with lyssavirus infection are bats in the subfamily *Murininae*, Genus *Murina*, more commonly known as the tube-nosed bats. In 2002, a bat that had entered an apartment in the town of Irkutsk was captured and died after approximately 10 days with signs of general exhaustion, poor appetite, and weakness. The bat was subjected to rabies diagnostics. Following antigenic and genetic typing, the virus was classified as a lyssavirus and named Irkut virus (IRKV) ([@bib33], [@bib139]). Initially, the bat was classified as a greater tube-nosed bat (*Murina leucogaster*), although the exact species of the bat from which IRKV was derived remains unclear. A single human case of rabies was reported due to infection with IRKV in 2007, although the bat species involved remains unknown ([@bib149]).

In 2009, another divergent lyssavirus, named Shimoni bat virus (SHIBV), was isolated from a dead Commerson's leaf-nosed bat (*Hipposideros commersoni*) during a search for pathogens in bats in Kenya ([@bib140]). Antigenically, SHIBV demonstrates similarity to MOKV and LBV, but is genetically divergent from these species ([@bib140]). Additional comparative serological surveys in *Rousettus aegyptiacus* bats and *Hipposideros commersoni* bats in roosts in Kenya where these species sympatrically roost demonstrated that the seroprevalence to SHIBV was equivalent in the presence or absence of *R. aegyptiacus* bats. These data supports the suggestion that *H. commersoni* is the host species of SHIBV ([@bib145]).

Although initially discovered in and predominantly associated with fruit-eating bat species (see [Section 6.3](#s0085){ref-type="sec"}), the Australian bat lyssavirus (ABLV) has also been associated with infection of insectivorous bat species. In Australia, 63 microbat species are detected ([@bib199]), although ABLV infection has only been confirmed by virus isolation in one insectivorous species, the yellow-bellied sheath-tailed bat (*Saccolaimus flaviventris*). This bat species is a member of the sheath-tailed bats in the family Emballonuridae found in Australia and Papua New Guinea. However, while no further direct isolations have been reported, serological evidence of exposure to ABLV has been shown in seven genera, representing five of the six families of Australian insectivorous bats, that is, *Chaerephon* and *Tadarida* (Molossidae), *Chalinolobus* and *Vespadelus* (Vespertilionidae), *Hipposideros* (Hipposideridae), *Macroderma* (Megadermatidae), and *Saccolaimus* (Emballonuridae) ([@bib8]). In the latter genus, the yellow-bellied sheath-tailed bat had significantly higher antibody prevalence (up to 62.5%) than other species, suggesting that this bat plays an important role in the ecology of ABLV ([@bib77]). Interestingly, viral antigen was not detected in any of the 668 clinically normal wild-caught microchiroptera collected around Australia; but only in sick, injured, or found dead animals, suggesting that the virus causes disease in bats.

Genetic characterization also revealed that the source of infection in the first human case of ABLV in 1996 was likely *S. flaviventris* ([@bib98]). In a second human case in 1998, subsequent sequence analysis of the viral isolate indicated it was of the variant characteristic of flying foxes ([@bib249]) (see [Section 6.3](#s0085){ref-type="sec"}).

3. Lyssaviruses and Frugivorous Bats {#s0085}
====================================

Frugivorous bats belong to the order Chiroptera, suborder Pteropodiformes, superfamily Pteropodidae. Frugivorous bats are present throughout most of the world, performing vital ecological roles such as pollinating flowers and dispersing fruit seeds ([@bib219]). Given this broad distribution, the detection of lyssaviruses within only a few species is somewhat surprising ([@bib24]). The *Pteropodidae* is divided into seven subfamilies with 186 total extant species, represented by 44 to 46 genera. Of these, only a few genera have been directly associated with lyssavirus infection ([Table 6.1](#t0010){ref-type="table"}).

Lyssavirus infection of frugivorous bats is largely restricted to the large fruit bats present across Africa and Australia, with numerous highly diverse lyssaviruses detected. Genetic analysis of isolates by a number of research groups has led to the suggestion that African bat populations are the original hosts for lyssaviruses ([@bib185]). However, despite this geographical bias in detection of lyssaviruses in African fruit bat populations, other fruit bat populations across the globe have also yielded different lyssaviruses. Here we describe the principal associations of lyssaviruses with frugivorous bats.

3.1. Detection of Lagos Bat Virus in Frugivorous Bats {#s0090}
-----------------------------------------------------

From an African perspective, RABV itself is completely absent from fruit bat populations, in direct contrast to the situation seen in carnivores. In place, LBV is the lyssavirus most frequently associated with different fruit bat species. Indeed, LBV or antibodies that neutralise LBV have been isolated from several fruit bat species, including the straw-colored fruit bat (*Eidolon helvum*), Wahlberg's epauletted fruit bat (*Epomorphorus wahlbergi*), and the Egyptian fruit bat (*Rousettus aegyptiacus*) (Dzkiwi et al., 2010; [@bib107], [@bib106]). Studies with African fruit bat species have detected a high seroprevalence of antibodies against LBV in these three different colonial fruit bat species, with antibody levels ranging from 14--67% and 29--46%, for the former two species, respectively. Initial studies showed that older *R. aegyptiacus* and *E. helvum* were shown to have a higher level of seroprevelance within populations of both species ([@bib141], [@bib70], [@bib106]). Data from *E. helvum* populations derived over a four-year study period demonstrated that seroprevalence in mature bats was significantly greater than that found in juvenile or sexually immature bats. Seroprevalence in sexually mature adults fluctuated between 23% (15--33%) and 49% (39--52%), with no significance seen between the proportion of seropositive sexually mature adults between sampling occasions over the study period ([@bib108]). Despite significant levels of LBV seropositivity within bat populations, attempts to isolate virus have often been problematic. Indeed, [@bib108] tested 796 oral swabs from healthy *E. helvum* using RT-PCR but did not detect viral RNA in any sample. Similarly, [@bib141] tested 931 oral swabs and 1,182 brain samples from at least 30 different species of bat by RT-PCR, with LBV RNA only being detected in a single *E. helvum* bat. As expected, high levels of viral RNA were detected in the brain, but also in the salivary gland and tongue, and so salivary excretion was postulated as the means of virus transmission ([@bib141]). Possible explanations for the seroprevalence levels seen in healthy *E. helvum* bats include: infection with seroconversion and recovery; seroconversion; and latent infection, although no evidence for latent infection has been shown. Further studies are required to enhance our knowledge of how LBV circulates in these bat populations ([@bib108]).

Both serological and genomic analyses have suggested that LBV isolates form four highly divergent lineages that in some cases are as divergent as some of the other, individually classified lyssaviruses. These have been tentatively termed lineages A to D. Lineage A includes isolates from Senegal (1985) ([@bib231]), a Kenyan (2007) ([@bib141]) and a French isolate (either Togolese or Egyptian origin, (1999) ([@bib16]); lineage B includes the original Nigerian isolate (1956) ([@bib35]); lineage C includes viruses from the Central African Republic (1974) ([@bib230]), Zimbabwe (1986) ([@bib129]), and South Africa (1980) ([@bib129]) (2003--2005) ([@bib158]); and lineage D includes a single isolate from Kenya taken from a healthy Egyptian fruit bat (2008) ([@bib140]). The most striking observation from these studies is the close sequence identity of isolates in lineage C that have been reported over a 25-year period. This suggests a high level of genome stability within these viruses ([@bib159]).

The detection of LBV in a rabid African water mongoose (*Atilax paludinosus*) was the first isolation of LBV from a terrestrial wildlife species ([@bib158]). Previous isolations in terrestrial mammals were all from domestic animals, including cats (*Felis catus*) ([@bib129]) and dogs (*Canis familiaris*) ([@bib167], [@bib159]). Alongside the rare detection of natural CST events, the potential for CST events has also, as with other lyssaviruses, been assessed experimentally. Early studies with experimental infection with LBV involved infection of guinea pigs (n = 2) and a monkey (*Cercocebus torquatus*) ([@bib35]). In these early studies, the virus was reported to be apathogenic and alongside other studies ([@bib18]) led to the conclusion that phylogroup II lyssaviruses, when inoculated by a peripheral route, were reduced in pathogenicity. Inoculation by the IC route, however, highlighted the ability of both LBV and MOKV to cause encephalitis and death ([@bib234]). Experimental studies with LBV, MOKV and RABV have suggested comparable mortality following IM inoculation of LBV and RABV, although IM inoculation with MOKV caused reduced mortality ([@bib157]).

As seen in the epidemiology of RABV and EBLV-1, CST events have also been reported for LBV infection. Indeed, the isolation of LBV from non-volant wildlife species such as mongoose highlights our poor understanding of the incidence and host range of lyssaviruses in Africa. Until molecular tools such as PCR are widely available to assess individual samples, the opportunity to characterize viruses at the molecular level will be missed, a fact highlighted by the detection of a IKOV ([@bib160]). Findings such as this reiterate the need for a thorough molecular analysis of samples to ensure a complete understanding of the epidemiology of these viruses ([@bib82]).

3.2. Australian Bat Lyssavirus and Flying Foxes {#s0095}
-----------------------------------------------

ABLV is predominantly associated with infection of frugivorous flying foxes. Genetic characterization of ABLV detected in *Pteropus* species have shown them to be genetically distinct from those isolated from insectivorous bats, and within each lineage the genetic variation is very narrow ([@bib98], [@bib101]). The initial isolation of ABLV was from a black flying fox (*Pteropus alecto*) in 1996 ([@bib54], [@bib86]). Since then, ABLV has been detected in all four frugivorous bat species present in Australia ([@bib86], [@bib97], [@bib98], [@bib101]). Unlike other lyssaviruses, no correlation has been seen between genetic variation and the geographical distribution of ABLV isolates within Australia ([@bib98]). Although all flying fox species seem to be affected by ABLV, no species-specific genetic associations have been observed ([@bib27], [@bib101]). Interestingly, ABLV is the only lyssavirus species which, from evidence gathered to date, has reservoirs in both mega- and microbats species. The correlation between CST and genetic distances of bat species, as demonstrated for North American bat RABV ([@bib229]), does not seem to fit as a model for the maintenance and transmission of ABLV. In any case, ABLV appears to be maintained in bat species in Australia. Furthermore, serosurveillance of bat populations in the Philippines and surrounding islands has suggested that lyssavirus infection of bats might be more widespread than previously thought ([@bib15]), although virus isolations are required due to cross-neutralization between phylogroup I viruses.

From a clinical perspective, the gray-headed flying fox (*Pteropus poliocephalus*) has been assessed for susceptibility to infection with ABLV with the outcome of clinical disease being seen in a proportion of the animals inoculated ([@bib164]). Three of ten intramuscularly inoculated animals developed clinical signs consistent with a lyssavirus infection, but virus neutralizing antibodies were only detected in five of the seven survivors ([@bib164]). In contrast, infection of companion animals with ABLV led to survival in all inoculated cats and dogs, although some animals did show transient neurological signs ([@bib165]). Although no viral antigen could be detected at post mortem in any tissues, strong serological profiles were seen in all infected animals.

3.3. Infection of Fruit Bats with Other Lyssaviruses {#s0100}
----------------------------------------------------

With the exception of LBV and ABLV, no other non-rabies lyssaviruses have been detected in frugivorous bats. However, from a molecular perspective, there have been reports of EBLV-1 RNA in Egyptian fruit bats (*Rousettus aegyptiacus*). In 1997, following the transport of a group of Egyptian fruit bats from a Dutch zoo to a Danish zoo, EBLV-1a RNA was detected in not only the exported bats but also within the Dutch colony from which the bats had been exported ([@bib200]). Furthermore, during the investigations surrounding these reports, no clinical disease was observed in any of the bats, and it was concluded that EBLV-1a was being maintained in healthy Egyptian fruit bats ([@bib252]). Following these reports, experimental studies with these bats have shown that, in some instances, these bats are able to survive infection with EBLV-1 following intracerebral inoculation ([@bib236]). Further studies are required to understand bat immune responses to lyssaviruses.

3.4. Interaction of Rabies Virus with New World Frugivorous Bats {#s0105}
----------------------------------------------------------------

The frugivorous bat populations of the Americas belong to the Phyllostomidae, and are genetically distant from the true Pteropodidae of the Old World. However, while the fruit bats in the Old World have been associated exclusively with infection of non-rabies lyssaviruses, in the New World the fruit bat populations are only associated with infection with RABV. [@bib191] was the first to describe rabies virus infection of frugivorous bats in Trinidad in 1931. This initial report was followed by several other reports of RABV infection of frugivorous bats, including the great fruit eating bat (*Artibeus lituratus*) ([@bib198], [@bib228]). In these cases, bats were reported to be displaying abnormal behavior and were characterized as being infected with RABV, although it is believed that this infection represented spillover from vampire bat species. [@bib67] reported that RABV isolates circulating in frugivorous species in South America were antigenically closely related to the vampire bat related viruses commonly described. [@bib217] genetically typed a vampire bat rabies variant in *Artibeus spp*. Most recently, complete genome sequencing has shown 97% identity across the entire genomes of a vampire bat derived and a frugivorous bat derived isolate ([@bib172]). Numerous reports across South America detail infection of fruit bats with RABV. But compared to the threat to both human and livestock populations from hematophagous bats ([Section 6.4](#s0110){ref-type="sec"}) and the infection of numerous insectivorous bats across the Americas ([Section 6.2](#s0015){ref-type="sec"}), the significance of rabies in frugivorous bats in South America is small ([@bib44], [@bib57]).

4. Rabies in Hematophagous Bats {#s0110}
===============================

Evolution has resulted in one group of bats that are highly effective in delivering a bite capable of damaging the skin and, as a consequence, are highly effective at transmitting rabies to other species: the vampire bats. Many of the biological adaptations of the vampire bat justify this claim, from the dentition that has evolved to cut through the skin of vertebrates, active secretion of saliva containing anti-coagulants to maintain blood flow in a wound, a colonial habit that provides the opportunity for transmission to con-specifics, and a wide selection of prey species that includes humans. For these reasons, vampire bats are a significant cause of death of livestock and responsible for increasing reports of rabies in humans.

Vampire bats are those that derive all their nutrition from feeding on the blood of other vertebrates. Only three genera of bats are blood feeders or hematophagus. All three belong to the family Phyllostomidae or New-World leaf-nosed bats, and each genus contains a single species ([@bib134]). These are the common vampire bat, *Desmodus rotundus*; the hairy-legged vampire bat, *Diphylla ecaudata*; and the white-winged vampire bat, *Diaemus youngi*. The latter species primarily feed on birds, whereas *D. rotundus* feeds primarily on mammals and is responsible for virtually all cases of rabies virus transmission. Therefore, this species will be considered in this section.

Blood-feeding by bats has not evolved outside of Central and South America, and all of the fossil evidence for vampire bats going back to the Pleistocine period (2.5 million years ago to 12,000 years ago) have been found in the Americas ([@bib14]). The association of rabies with the vampire bat is a relatively recent observation, despite the obvious advantage the species has in transmitting rabies. A number of authors have speculated that rabies was present within vampire bat species prior to the Spanish conquest of the New World in the fifteenth century. This is based mainly on the writings of the Spanish colonists ([@bib64]) and the limited information from the indigenous peoples that has survived and been translated ([@bib248]). It is also speculated that the introduction of livestock and horses by the Spanish settlers increased the numbers of potential prey animals and has led to an increase in the population of vampire bats ([@bib99]). A further factor that may have increased both the numbers of vampire bats and brought them into closer contact with humans has been the introduction of manmade structures, such as mines and bridges, that provide additional roosting sites ([@bib99]).

Historically, early writings report rabies as the cause of disease in cattle in southern Brazil following detection of Negri bodies in the brains of cattle ([@bib43], [@bib105]). However, the link to vampire bats as the cause was not initially accepted, despite the absence of rabid dogs in the affected areas. Later reports, primarily by Joseph Lennox Pawan (1887--1957) on the island of Trinidad, established clearly the link between rabies in vampire bats and outbreaks in livestock in 1925 and humans in 1929 ([@bib110], [@bib192]). The close proximity between Trinidad and the South American mainland suggested that migration of vampire bats infected with RABV was the likely explanation for the emergence of disease. One of the striking features of these reports was the observation of vampire bat activity during the day and what appeared to be aggressive attacks on humans and tethered livestock ([@bib191]).

4.1. Biology of Vampire Bats {#s0115}
----------------------------

The common vampire bat (*D. rotundus*) is widely distributed from northern Mexico to central Chile and northern Argentina. It occupies a range of ecosystems including rainforests, wetlands, and desert. It is also found at a range of elevations from sea level to 3,500 meters and is not present over much of the Andes and central Mexico ([@bib134]).

Common vampire bats roost in colonies of variable size, ranging from less than 10 bats to over 300. Occasionally colonies of 2000 or more individuals have been reported ([@bib14]). Common vampire bats often roost in caves with other species, and both autogrooming and allogrooming are common, potentially providing opportunities for spread of RABV. Furthermore, common vampire bats participate in altruistic feeding, whereby a bat that has fed will regurgitate blood for one that has not. This could provide a further opportunity for transmission of virus.

4.2. Rabies in the Vampire Bat {#s0120}
------------------------------

[@bib191] described the appearance of rabies in wild-caught bats. These included both the furious and paralytic forms, as well as sudden death with no apparent disease. [@bib176] conducted the definitive experimental study using RABV prepared from a naturally infected vampire bat. They demonstrated that both intramuscular and subcutaneous inoculation of captive vampire bats resulted in the infection of the bat and that this infection was fatal. Many of the infected bats excreted virus in saliva prior to development of disease but showed no evidence for a carrier status whereby virus could be excreted long-term in a healthy vampire bat. Later studies confirmed the susceptibility of vampire bats to intramuscular inoculation of virus and reported a decrease in blood consumption and dehydration as early signs of infection. Wing and hind limb paralysis was observed ([@bib1]), as well as muscular spasms and tremors ([@bib4]). Seroconversion was observed in a number of bats that survived inoculation with RABV. A further study observed salivary excretion on three occasions by a small number of bats that survived inoculation with RABV ([@bib3]), although this has not been corroborated by other researchers.

4.3. Epidemiology of Rabies in Vampire Bats {#s0125}
-------------------------------------------

Characterization of RABV in reservoirs in the New World was initially attempted using antigenic differentiation using panels of monoclonal antibodies raised against the RABV nucleocapsid protein ([@bib204], [@bib68]). This initially classified rabies viruses as those transmitted by terrestrial and non-terrestrial reservoirs and proved useful to identify the source of infection in humans. This has been further developed to distinguish between a variety of antigenic variants, of which there are currently 11 variants that are present across North and South America ([@bib243]). This approach to classification has been further refined through the use of nucleic acid sequence data derived from discrete fragments of the RABV genome. This began with short fragments of the nucleoprotein gene ([@bib222]), which corroborated the separation of reservoirs based on antigenic variation and allowed further discrimination that began to link particular RABV variants with species ([@bib182], [@bib84], [@bib172]).

The main purpose of molecular epidemiology is to trace the variation of RABV in reservoir populations in fine detail. This has been achieved for the rabies virus variants associated with vampire bats, particularly when this has affected cattle ([@bib132], [@bib133]) or humans ([@bib58], [@bib26], [@bib45]). The major economic impact of vampire bat predation is through the transmission of rabies to livestock causing death. Estimates have suggested that over a 9-year period losses due to livestock death in the Americas were over \$50 million ([@bib29]). Seasonal peaks in the vampire bat population due to births have been associated with an increase in livestock rabies ([@bib152]).

Attacks on humans are rare; however, one of the most recent cases of rabies in Louisiana occurred in a migrant worker who was likely to have contracted the disease while in his home state of Michoacán, Mexico ([@bib21]). Anecdotal evidence suggests that the incidence of vampire bat attacks on people resulting in rabies is on the increase. This could be due to an actual increase in virus prevalence in the reservoir, or an increase in attacks by vampire bats on humans, or an increase in incident reporting. Changes in human activity have been responsible for increasing vampire predation. For example, removal of livestock can result in increased biting attacks on humans. Many of the reported outbreaks occur in remote communities with limited access to health care professionals and facilities ([@bib58], [@bib95], [@bib212]).

4.4. Control of Vampire Bats and Future Perspectives {#s0130}
----------------------------------------------------

The main approach to the control of RABV transmission has been to control the bat reservoir, mainly through destruction. This takes the form of habitat destruction, that is, destroying roosting caves, or direct trapping and killing of vampire bats ([@bib161]). However, this often results in the destruction of other bat species. A more focused approach is the application of anticoagulants, either to cattle ([@bib233]), or applied directly to captured bats, which are then released. This approach provides a short-term respite but creates an ecological niche that tends to be filled quickly by dispersing vampire bats. Parenteral vaccination of cattle is an effective means of preventing death from rabies infection, although is costly and requires repeated application to every generation. An alternative to this is oral vaccination with plant-derived feed that has been genetically modified to express RABV glycoprotein ([@bib166], [@bib153]). Further investigations have considered vaccination of vampire bats ([@bib1], [@bib2]). These studies demonstrated that anti-rabies vaccination in the common vampire bat was effective but is costly and unlikely to reach the widespread populations found throughout Latin America.

A further consideration is the potential for vampire bats to increase their range both north into the United States and south to larger areas of Argentina. Climate change models that predict modest increases in winter temperatures suggest that the range of the common vampire bat could spread north into the United States ([@bib171]). Despite their effectiveness at transmitting RABV, there is no evidence for transmission of vampire bat variants to other reservoirs (bats or dogs) with establishment of the variant within the new host and sustained transmission.

5. Conclusions {#s0135}
==============

In summary, bats have played and continue to play a key role in lyssavirus ecology and evolution. Clearly, many different bat species from different geographical locations and with different feeding habits and ecologies have been found to be infected with different lyssaviruses. However, the unusual distribution of lyssaviruses around the world and their association with particular bat species remains unexplained. Despite the genetic divergence of lyssaviruses detected in different bat species, the disease is similar in all species observed, causing neurological disease where clinical signs are observed. With the exception of vampire bats, the public health risk of rabies in bats remains low, although the consequences of infection are severe. In all species, the mechanisms by which abortive infections occur are unclear. However, there remains no convincing evidence for the existence of a carrier status in bats. While it appears that CST events of lyssaviruses to other mammals, including humans, are rare, the potential for sustained transmission in non-bat hosts exists, although further studies are needed in order to define the many gaps in our understanding of bat lyssaviruses.
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[^1]: NR Not Reported.

[^2]: Data obtained from [@bib174]. A total of 31,380 bats were tested with 1,946 (6.2%) testing positive for rabies virus. Bat species that were negative have been removed from the table.

[^3]: Data obtained from [@bib31]. A total of 24,298 bats were tested with 1,430 (5.9%) testing positive for rabies virus.

[^4]: related to transplantation in four cases.
